X
27Apr

[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19

While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By: Arnall Golden Gregory LLP
Source Url: https://www.jdsupra.com/legalnews/six-things-you-need-to-know-about-life-s-95385/

Related

Eugene Scalia May Become Next Leader Of Labor Department

When Alexander Acosta resigned as Secretary of Labor, his deputy, Patrick Pizzella, took over as Act...

Read More >

Merger Control in Europe Following COVID-19

Whereas COVID-19 is likely to delay review timelines of many M&A deals, it may also make some approv...

Read More >

Report from EEOC Hearing on EEO-1 Component 2—Should It Stay or Should It Go?

On November 20, 2019, the EEOC held a public hearing at its headquarters in Washington, DC, regardin...

Read More >

Fraternizing May Lead to Your Partner’s Promotion, Your Discharge, and Possibly a Lawsuit

At what point does a company’s application of its anti-fraternization policy become sex discriminat...

Read More >

Can We See An Instant Replay? Video Evidence Affirmed To Support Finding Of No Harassment

The California Court of Appeal, in its recent decision in Schmidt, et al. v. Superior Court, County ...

Read More >